Evidence map›Paper›PMID 34241579›Full record

ReviewTissue barriers2021

Virus-associated disruption of mucosal epithelial tight junctions and its role in viral transmission and spread.

Sharof Tugizov

Open access · bronzeAbstract readReview
In one paragraph

Review in Tissue barriers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. EPsInternational journal of molecular sciences · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sharof TugizovDepartment of Medicine, School of Medicine, University of California-San Francisco, San Francisco, CA, USA.
University of California, San Francisco · US

Funding

Role of oral herpesvirus microbiota in pathogenesis of HIV mother to child transmissionR01DE028129 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2018 to 2022
$2.6M
Role of HIV in acceleration of HPV malignancyR01CA232887 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA232887NIDCR NIH HHS R01 DE028129
6 · The paper itself

Abstract

Oropharyngeal, airway, intestinal, and genital mucosal epithelia are the main portals of entry for the majority of human pathogenic viruses. To initiate systemic infection, viruses must first be transmitted across the mucosal epithelium and then spread across the body. However, mucosal epithelia have well-developed tight junctions, which have a strong barrier function that plays a critical role in preventing the spread and dissemination of viral pathogens. Viruses can overcome these barriers by disrupting the tight junctions of mucosal epithelia, which facilitate paracellular viral penetration and initiate systemic disease. Disruption of tight and adherens junctions may also release the sequestered viral receptors within the junctional areas, and liberation of hidden receptors may facilitate viral infection of mucosal epithelia. This review focuses on possible molecular mechanisms of virus-associated disruption of mucosal epithelial junctions and its role in transmucosal viral transmission and spread.

Indexed as

Tight JunctionsVirus DiseasesEpitheliumHumansMucous Membranedisruption of epithelial junctionsmucosal epitheliumVirus

Identifiers

PMID34241579
PMCPMC8794520
OpenAlexW3181307218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.